HVTN130/HPTN089

Closed to enrollment and study follow-up A Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of combinations of monoclonal antibodies administered via intravenous infusion in healthy, HIV-uninfected adults Web Links: https://www.clinicaltrials.gov/ct2/show/NCT03928821 https://www.hptn.org/research/studies/130_089 https://www.hptn.org/sites/default/files/inline-files/HVTN130-HPTN089_v1.0_loa1_FINAL.pdf